Markets:

Overview

News

Currencies

International

Treasuries

Alkermes plc - Ordinary Shares (NQ:ALKS)

41.53 +1.59 (+3.98%)

Streaming Delayed Price Updated: 10:26 AM EDT, May 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Alkermes plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

NASDAQ:ALKS—A High-Growth Stock Gearing Up for Its Next Upward Move. ↗

November 14, 2023

Is ALKERMES PLC (NASDAQ:ALKS) on the Verge of a Major Breakout as a Strong Growth Stock?

Via Chartmill

7 Healthcare Stocks That Are Poised to Become the Next Unicorns ↗

November 09, 2023

Discover healthcare stocks with remarkable potential for growth and "unicorn" status in the ever-evolving world of healthcare investments.

Via InvestorPlace

For those who appreciate growth without the sticker shock, NASDAQ:ALKS is worth considering. ↗

November 07, 2023

ALKERMES PLC (NASDAQ:ALKS) stands out as a growth opportunity that won't break the bank.

Via Chartmill

NASDAQ:ALKS, an undervalued stock with good fundamentals. ↗

October 26, 2023

ALKERMES PLC (NASDAQ:ALKS) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.

Via Chartmill

Why Alkermes Stock Is Sinking Today ↗

October 25, 2023

The biotech company's Q3 revenue and earnings looked great, but the results weren't enough to wow investors.

Via The Motley Fool

Alkermes Q3 Earnings Top Consensus, On Track To Separate Oncology Business, Reaffirms FY23 Outlook ↗

October 25, 2023

Alkermes PLC (NASDAQ: ALKS) reported Q3 FY23 adjusted EPS of $0.64 compared to $0.02 a year ago, beating the

Via Benzinga

Why NASDAQ:ALKS Is a Promising High-Growth Stock in the Midst of Consolidation. ↗

October 23, 2023

ALKERMES PLC (NASDAQ:ALKS), a strong growth stock, setting up for a breakout.

Via Chartmill

Alkermes Honors Women's Equality Day

August 28, 2023

Via ACCESSWIRE

Earnings Preview: Alkermes ↗

July 25, 2023

Via Benzinga

Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

October 25, 2023

Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ.

Via Benzinga

Alkermes Plummets In Huge Volume. Why One Analyst Says The Reaction Is Overdone. ↗

October 23, 2023

Analysts say Alkermes' drug is clearly active. But investors have concerns.

Via Investor's Business Daily

Where Alkermes Stands With Analysts ↗

June 07, 2023

Via Benzinga

Alkermes Earnings Perspective: Return On Capital Employed ↗

April 27, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023 ↗

October 24, 2023

Via Benzinga

While growth is established for NASDAQ:ALKS, the stock's valuation remains reasonable. ↗

October 17, 2023

Looking for growth without the hefty price tag? Consider ALKERMES PLC (NASDAQ:ALKS).

Via Chartmill

NASDAQ:ALKS is showing good growth, while it is not too expensive. ↗

September 26, 2023

Despite its growth, ALKERMES PLC (NASDAQ:ALKS) remains within the realm of affordability.

Via Chartmill

Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2023 ↗

October 17, 2023

Via Benzinga

Hovnanian Enterprises, LexinFintech Holdings And Other Big Stocks Moving Higher On Wednesday ↗

August 30, 2023

U.S. stocks traded mixed, with the Dow Jones falling around 10 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 17, 2023

Via Benzinga

3 Top Biotech Stocks Defying the Bear Market ↗

August 10, 2023

Biotech is still booming, if you pick the right biotech stocks.

Via The Motley Fool

Alkermes Clocks Over 100% Jump In Q2 Sales and Profits On Reinstated Product Royalty From Long-Acting Invega ↗

July 26, 2023

Alkermes plc (NASDAQ: ALKS) reported Q2 adjusted EPS of $0.55 compared to $0.06 a year ago, missing the consensus of $0.56

Via Benzinga

Sarissa Capital Urges Alkermes Shareholders to Vote “FOR” Sarah Schlesinger and “WITHHOLD” Incumbent Director Richard Gaynor

June 28, 2023

From Sarissa Capital Management LP

Via Business Wire

Sarissa Issues Presentation Highlighting Sarissa Nominees Are Qualified to Create Value for Alkermes Shareholders

June 26, 2023

From Sarissa Capital Management LP

Via Business Wire

Independent Proxy Advisory Firm ISS Agrees With Sarissa Capital That Shareholders’ Interests Would Be Best Served With Direct Shareholder Representation on the Alkermes Board

June 22, 2023

From Sarissa Capital Management LP

Via Business Wire

Independent Proxy Advisory Firm ISS Concludes That Sarissa Capital Has Made a Compelling Case for Change to the Alkermes Board

June 20, 2023

From Sarissa Capital Management LP

Via Business Wire

Sarissa Issues Presentation Highlighting the Need for Shareholder Representation on the Alkermes Board

June 15, 2023

From Sarissa Capital Management LP

Via Business Wire

Sarissa Urges Shareholders to Vote for Sarissa Nominees to Provide Much Needed Oversight and Accountability to Alkermes

June 13, 2023

From Sarissa Capital Management LP

Via Business Wire

Sarissa Capital Highlights Misleading Claims Made by Alkermes in Its Attempt to Thwart Shareholder Representation on the Board

June 09, 2023

From Sarissa Capital Management LP

Via Business Wire

Alkermes Raises FY23 Outlook Following Arbitration Award from Janssen Agreements ↗

June 06, 2023

Via Benzinga

Sarissa Urges Alkermes Shareholders to Vote the Universal Blue Card to Upgrade Alkermes for the Benefit of Shareholders

June 05, 2023

From Sarissa Capital Management LP

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.